[
  {
    "tier": "Tier 1",
    "company": "Roquette Suisse",
    "hq_country": "Switzerland",
    "industry": "Cosmetics Ingredients",
    "revenue": "Approx. 4.0B",
    "situations": "Significant Growth, Resource Constraints",
    "classification": "Unclear, Likely",
    "priority_score": "RC: 4",
    "key_evidence": "MP: 0",
    "sources": "SG: 2",
    "_score_int": 4,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Bobst",
    "hq_country": "Switzerland",
    "industry": "Precision Manufacturing",
    "revenue": "Approx. 1.8B",
    "situations": "Margin Pressure, Significant Growth",
    "classification": "Likely, Likely",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 4",
    "sources": "SG: 4",
    "_score_int": 0,
    "_frequency": 3
  },
  {
    "tier": "Tier 1",
    "company": "Vetropack",
    "hq_country": "Switzerland",
    "industry": "Packaging Materials",
    "revenue": "Approx. 800M",
    "situations": "Significant Growth",
    "classification": "LIKELY",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 4",
    "_score_int": 0,
    "_frequency": 2
  },
  {
    "tier": "Tier 1",
    "company": "Lonza",
    "hq_country": "Switzerland",
    "industry": "CDMO",
    "revenue": "Approx. 8.0B",
    "situations": "Significant Growth, Supply Chain Disruption",
    "classification": "Likely, Likely",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 5",
    "_score_int": 0,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Bachem",
    "hq_country": "Switzerland",
    "industry": "Peptide CDMO",
    "revenue": "Approx. 0.6B",
    "situations": "Significant Growth",
    "classification": "Confirmed",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 8",
    "_score_int": 0,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Siegfried",
    "hq_country": "Switzerland",
    "industry": "CDMO",
    "revenue": "Approx. 1.2B",
    "situations": "Margin Pressure, Significant Growth",
    "classification": "Likely, Unclear",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 4",
    "sources": "SG: 3",
    "_score_int": 0,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Vifor Pharma",
    "hq_country": "Switzerland",
    "industry": "Pharmaceuticals",
    "revenue": "Approx. 2.0B",
    "situations": "Significant Growth, Supply Chain Disruption",
    "classification": "Unclear, Likely",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 2",
    "_score_int": 0,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Straumann",
    "hq_country": "Switzerland",
    "industry": "Dental Implants",
    "revenue": "Approx. 2.5B",
    "situations": "Significant Growth",
    "classification": "CONFIRMED",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 8",
    "_score_int": 0,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Sonova",
    "hq_country": "Switzerland",
    "industry": "Hearing Healthcare",
    "revenue": "Approx. 4.0B",
    "situations": "Significant Growth",
    "classification": "LIKELY",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 6",
    "_score_int": 0,
    "_frequency": 1
  },
  {
    "tier": "Tier 1",
    "company": "Ypsomed",
    "hq_country": "Switzerland",
    "industry": "Injection Systems",
    "revenue": "Approx. 0.6B",
    "situations": "Significant Growth",
    "classification": "LIKELY",
    "priority_score": "RC: 0",
    "key_evidence": "MP: 0",
    "sources": "SG: 6",
    "_score_int": 0,
    "_frequency": 1
  }
]